Markers of apoptosis and cellular death in patients on chronic hemodialysis.

被引：0
|
作者：
Soubassi, LP
Sarandakou, A
Kotsis, B
Chaniotis, DI
Zerefos, SN
Soubassi, SP
Zerefos, NS
机构：
[1] Univ Athens, Dept Clin Therapeut, Athens, Greece
[2] Aretaieion Univ Athens, Hormone Lab, Athens, Greece
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2002年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
81
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
  • [1] Survival analysis of patients undergoing chronic hemodialysis.
    Kim, SS
    Kim, JS
    Kim, JH
    Hwang, PJ
    Na, GR
    Oh, SM
    Bin, KT
    Lee, KW
    Han, MH
    Lee, KS
    Sin, YT
    KIDNEY INTERNATIONAL, 1998, 54 (05) : 1802 - 1802
  • [2] Predictors of stroke in patients receiving chronic hemodialysis.
    Iseki, K
    Fukiyama, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1169 - A1169
  • [3] Tips for patients with refractory ascites and chronic hemodialysis.
    Ochs, A
    Rossle, M
    Haag, K
    Piotraschke, J
    Schollmeyer, P
    Blum, HE
    HEPATOLOGY, 1996, 24 (04) : 1275 - 1275
  • [4] Cellular activation and apoptosis as markers of inflammation induced by hemodialysis
    Carracedo, J
    Ramírez, R
    Madueño, JA
    Soriano, S
    Rodríguez-Benot, A
    Rodríguez, M
    Martín-Malo, A
    Aljama, P
    NEFROLOGIA, 2001, 21 : 40 - 44
  • [5] Plasma isoprostanes markers of oxidative stress in patients on long term hemodialysis.
    Walter, MF
    Levin, NW
    Nightingale, ZD
    Handelman, GJ
    FASEB JOURNAL, 1999, 13 (04): : A564 - A564
  • [6] Low levels of antioxidant defenses in chronic renal patients in hemodialysis.
    deCavanagh, EMV
    Carrasquedo, F
    Scrivo, D
    Wassermann, A
    Fraga, CG
    Ferder, L
    Inserra, F
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1070 - A1070
  • [7] Development of an HCV risk stratification algorithm for patients on chronic hemodialysis.
    Ma, WL
    Rossi, S
    Michael, B
    Dunn, S
    Hyslop, T
    Herrine, SK
    HEPATOLOGY, 2001, 34 (04) : 574A - 574A
  • [8] Telavancin pharmacokinetics in patients with chronic kidney disease receiving hemodialysis.
    Gharibian, Katherine N.
    Lewis, Susan J.
    Heung, Michael
    Segal, Jonathan H.
    Salama, Noha N.
    Mueller, Bruce A.
    PHARMACOTHERAPY, 2016, 36 (12): : E256 - E256
  • [9] Diastolic dysfunction in chronic renal failure patients under hemodialysis.
    Douchet, MP
    Couppie, P
    Chantrel, F
    Kuntz, C
    Hannedouche, T
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1996, 45 (10): : 589 - 592
  • [10] EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS
    Kirmizis, D.
    Papagianni, A.
    Belechri, A-M
    Efstratiadis, G.
    Alexopoulos, E.
    Memmos, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345